前收市價 | 0.9000 |
開市 | 0.9000 |
買盤 | 1.0500 |
賣出價 | 1.2000 |
拍板 | 7.50 |
到期日 | 2025-01-17 |
今日波幅 | 0.9000 - 0.9000 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 134 |
In this article, we’re going to take a look at 13 best biotech stocks to buy under $20. To see more stocks that made the list, you can skip ahead and jump straight to the top 5 best biotech stocks to buy under $20. When it comes to investing, few industries are as exciting to […]
Akero (AKRO) reports positive results from its mid-stage study of efruxifermin in pre-cirrhotic metabolic dysfunction-associated steatohepatitis patients at week 96. The stock gains 12%.
The average of price targets set by Wall Street analysts indicates a potential upside of 121.5% in 89BIO (ETNB). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.